Group IIA-Secreted Phospholipase A2in Human Serum Kills Commensal but Not Clinical Enterococcus faecium Isolates
- 1 August 2018
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 86 (8)
Abstract
Human innate immunity employs cellular and humoral mechanisms to facilitate rapid killing of invading bacteria. The direct killing of bacteria by human serum is mainly attributed to the activity of the complement system that forms pores in Gram-negative bacteria. Although Gram-positive bacteria are considered resistant to serum killing, we here uncover that normal human serum effectively kills Enterococcus faecium. Comparison of a well-characterized collection of commensal and clinical E. faecium isolates revealed that human serum specifically kills commensal E. faecium strains isolated from normal gut microbiota, but not clinical isolates. Inhibitor studies show that the human group IIA secreted phospholipase A2 (hGIIA), but not complement, is responsible for killing of commensal E. faecium strains in human normal serum. This is remarkable since the hGIIA concentration in ‘non-inflamed' serum was considered too low to be bactericidal against Gram-positive bacteria. Mechanistic studies showed that serum hGIIA specifically causes permeabilization of commensal E. faecium membranes. Altogether, we find that a normal serum concentration of hGIIA effectively kills commensal E. faecium and that hGIIA resistance of clinical E. faecium could have contributed to the ability of these strains to become opportunistic pathogens in hospitalized patients.Keywords
All Related Versions
Funding Information
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (91713303)
- EC | Horizon 2020 Framework Programme (639209)
- EC | FP7 | FP7 Health (282004)
This publication has 56 references indexed in Scilit:
- Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal StrainsmBio, 2013
- Restricted Gene Flow among Hospital Subpopulations of Enterococcus faeciummBio, 2012
- Enterococcus faecium Stimulates Human Neutrophils via the Formyl-Peptide Receptor 2PLOS ONE, 2012
- The Antibacterial Lectin RegIIIγ Promotes the Spatial Segregation of Microbiota and Host in the IntestineScience, 2011
- Human Transferrin Confers Serum Resistance against Bacillus anthracisJournal of Biological Chemistry, 2010
- Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity islandBMC Genomics, 2010
- Group X Phospholipase A2 Stimulates the Proliferation of Colon Cancer Cells by Producing Various Lipid MediatorsMolecular Pharmacology, 2009
- Neutrophils Are Essential for Rapid Clearance ofEnterococcus faeciumin MiceInfection and Immunity, 2009
- Wall Teichoic Acid Deficiency inStaphylococcus aureusConfers Selective Resistance to Mammalian Group IIA Phospholipase A2and Human β-Defensin 3Infection and Immunity, 2008
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005